Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 734

1.

Systematic review: cardiac resynchronization in patients with symptomatic heart failure.

McAlister FA, Ezekowitz JA, Wiebe N, Rowe B, Spooner C, Crumley E, Hartling L, Klassen T, Abraham W.

Ann Intern Med. 2004 Sep 7;141(5):381-90. Epub 2004 Aug 16. Review. Erratum in: Ann Intern Med. 2005 Feb 15;142(4):311.

PMID:
15353430
2.

Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure.

Al-Majed NS, McAlister FA, Bakal JA, Ezekowitz JA.

Ann Intern Med. 2011 Mar 15;154(6):401-12. doi: 10.7326/0003-4819-154-6-201103150-00313. Epub 2011 Feb 14.

PMID:
21320922
4.

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C; REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group.

J Am Coll Cardiol. 2008 Dec 2;52(23):1834-43. doi: 10.1016/j.jacc.2008.08.027. Epub 2008 Nov 7.

5.

Cardiac resynchronization therapy in patients with heart failure: systematic review.

Lemos JĂșnior HP, Atallah AN.

Sao Paulo Med J. 2009 Jan;127(1):40-5. Review.

6.

Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?

Turley AJ, Raja SG, Salhiyyah K, Nagarajan K.

Interact Cardiovasc Thorac Surg. 2008 Dec;7(6):1141-6. doi: 10.1510/icvts.2008.183707. Epub 2008 Jun 9. Review.

PMID:
18541605
7.

Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.

Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, DeMarco T, Mann D, Yong P, Galle E, Ecklund F, Bristow M.

Circulation. 2007 Jan 16;115(2):204-12. Epub 2006 Dec 26.

8.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

9.

Metaanalysis on effects of cardiac resynchronization therapy in heart failure patients with narrow QRS complex.

Jeevanantham V, Zareba W, Navaneethan S, Fitzgerald D, Yu CM, Achilli A, Bax J, Daubert J.

Cardiol J. 2008;15(3):230-6.

10.

Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis.

Adabag S, Roukoz H, Anand IS, Moss AJ.

J Am Coll Cardiol. 2011 Aug 23;58(9):935-41. doi: 10.1016/j.jacc.2011.05.022. Review.

11.

Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.

Sunsaneewitayakul B, Sitthisook S, Sangwatanaroj S, Prechawat S, Songmuang SB.

J Med Assoc Thai. 2007 Jul;90(7):1458-66.

PMID:
17710992
12.
13.

The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators.

N Engl J Med. 2005 Apr 14;352(15):1539-49. Epub 2005 Mar 7.

14.

MERIT-HF mortality and morbidity data.

Hjalmarson A, Fagerberg B.

Basic Res Cardiol. 2000;95 Suppl 1:I98-103. Review.

PMID:
11192362
15.

Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing.

Leon AR, Greenberg JM, Kanuru N, Baker CM, Mera FV, Smith AL, Langberg JJ, DeLurgio DB.

J Am Coll Cardiol. 2002 Apr 17;39(8):1258-63.

16.

Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials.

Ezekowitz JA, McAlister FA.

Eur Heart J. 2009 Feb;30(4):469-77. doi: 10.1093/eurheartj/ehn543. Epub 2008 Dec 9. Review.

PMID:
19066207
17.

Cardiac resynchronization therapy in patients with mild heart failure: a systematic review and meta-analysis.

Santangeli P, Di Biase L, Pelargonio G, Dello Russo A, Casella M, Bartoletti S, Burkhardt JD, Mohanty P, Santarelli P, Natale A.

J Interv Card Electrophysiol. 2011 Nov;32(2):125-35. doi: 10.1007/s10840-011-9584-y. Epub 2011 May 19. Review.

PMID:
21594629
18.

Cardiac resynchronization therapy in patients with chronic heart failure: pathophysiology and current experience.

Seidl K, Rameken M, Vater M, Senges J.

Am J Cardiovasc Drugs. 2002;2(4):219-26. Review.

PMID:
14727967
19.

Cardiac resynchronization therapy and implantable cardiac defibrillators in left ventricular systolic dysfunction.

McAlister FA, Ezekowitz J, Dryden DM, Hooton N, Vandermeer B, Friesen C, Spooner C, Rowe BH.

Evid Rep Technol Assess (Full Rep). 2007 Jun;(152):1-199. Review.

20.

Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction.

Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C, McAlister FA.

Ann Intern Med. 2007 Aug 21;147(4):251-62. Review.

PMID:
17709759

Supplemental Content

Support Center